Endoscopic Mucosal Resection and Cellular Matrix

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

June 20, 2017

Study Completion Date

June 20, 2017

Conditions
Barretts Esophagus With High Grade DysplasiaBarrett Adenocarcinoma
Interventions
DEVICE

Acell MatriStem® Surgical Matrix

Extracellular matrix (ECM) product that is composed of collagen and natural proteins that provide a re-absorbable scaffold for tissue remodeling to facilitate constructive healing following endoscopic submucosal resection (EMR). Covers the defect site following mucosal resection using endoscopy clips or X-tac. The device will remain attached to the esophagus and integrate with native tissue over time.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03240679 - Endoscopic Mucosal Resection and Cellular Matrix | Biotech Hunter | Biotech Hunter